Skip to Main Content

Author Details

Andrei Goga
University of California San Francisco
1993
79
44
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37398487The oncogene cyclin D1 promotes bipolar spindle integrity under compressive force.bioRxiv2023
34974281NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation.Transl Oncol2022
35666959Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice.JCO Precis Oncol2022
36414627Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.Nat Commun2022
36138165Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism.Nat Microbiol2022
36153537Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.Breast Cancer Res2022
32738449MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.J Hepatol2021
34489453Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.NPJ Breast Cancer2021
34118203Oncogene-regulated release of extracellular vesicles.Dev Cell2021
33466329In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer.Cancers (Basel)2021
32160543MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities.Cell Rep2020
30478424Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.Nat Med2019
29795293Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.Nat Commun2018
30165047microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.Gastroenterology2018
29942081Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.Nat Chem Biol2018
30397354Cancer cells exploit an orphan RNA to drive metastatic progression.Nat Med2018
29606307New Horizons in Advocacy Engaged Physical Sciences and Oncology Research.Trends Cancer2018
28077268Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques.Magn Reson Imaging2017
28219903MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.EMBO Rep2017
28270600Diverse regulation of mammary epithelial growth and branching morphogenesis through noncanonical Wnt signaling.Proc Natl Acad Sci U S A2017
28443280<i>In vivo</i> Reprogramming of Cancer Metabolism by MYC.Front Cell Dev Biol2017
29057876Comprehensive analysis of normal adjacent to tumor transcriptomes.Nat Commun2017
28716678Cancer recurrence monitoring using hyperpolarized [1-<sup>13</sup>C]pyruvate metabolic imaging in murine breast cancer model.Magn Reson Imaging2017
26950360Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.Nat Med2016
27775705PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression.Nat Med2016
27380425Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell Pathogenicity.ACS Chem Biol2016
27185638GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.Cell Chem Biol2016
25501949Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.Cancer Discov2015
26320939Biogenesis, delivery, and function of extracellular RNA.J Extracell Vesicles2015
26585277Fas-Activated Mitochondrial Apoptosis Culls Stalled Embryonic Stem Cells to Promote Differentiation.Curr Biol2015
26472073Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.Hum Mol Genet2015
26416748Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.Nature2015
26134322Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.PLoS Genet2015
25945974Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.ACS Chem Biol2015
25956709Direct and indirect targeting of MYC to treat acute myeloid leukemia.Cancer Chemother Pharmacol2015
25624489Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.Proc Natl Acad Sci U S A2015
25733019CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation.Stem Cell Reports2015
23412881Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS.Magn Reson Med2014
25143484Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.Blood2014
24738946Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.ACS Chem Biol2014
24857145Taking on challenging targets: making MYC druggable.Am Soc Clin Oncol Educ Book2014
24711549Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.J Clin Oncol2014
24356096Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.Cancer Discov2014
23913442MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.Hepatology2014
23993094Endogenous nuclear RNAi mediates behavioral adaptation to odor.Cell2013
24137534A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.Elife2013
22169407Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea.Magn Reson Imaging2012
23042294IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2.Science2012
22802621Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma.Proc Natl Acad Sci U S A2012
22853430HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.Biochem J2012
  • 1 - 50 of 79

Recommended Authors

Shruthy Suresh
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Amanda R Wasylishen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 2
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 4
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 7
Justin Cidado
Oncology R&D
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 3
Mark A Gregory
University of Colorado Anschutz Medical Campus
Career Start Year 2000
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 5
Michael A White
University of Georgia
Career Start Year 1994
Number of shared co-authors 5
Nabeel Bardeesy
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 9
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 0
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 3
Linda Z Penn
University of Toronto
Career Start Year 1990
Number of shared co-authors 4
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 6
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 2
Eldad Zacksenhaus
University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 2
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 2
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 12
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
Rosalie C Sears
Oregon Health and Science University
Career Start Year 1987
Number of shared co-authors 3
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 8
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 5

Collaborators

Owen N Witte
University of California los angeles
Co-authored papers 9
Alicia Y Zhou
University of California san francisco
Co-authored papers 9
Noelle E Huskey
Co-authored papers 8
Dai Horiuchi
Integrated Graduate School of Medicine, University of Yamanashi
Co-authored papers 8
Daniel K Nomura
University of California berkeley
Co-authored papers 7
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers 6
Peder E Z Larson
University of California San Francisco
Co-authored papers 6
Jami McLaughlin
University of California los angeles
Co-authored papers 6
Kevan M Shokat
University of California San Francisco
Co-authored papers 5
Scott A Oakes
Pritzker School of Medicine, University of Chicago
Co-authored papers 4
Michael T McManus
Co-authored papers 4
Alexandra Corella
Fred Hutchinson Cancer Research Center
Co-authored papers 4
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Christina Yau
University of California San Francisco
Co-authored papers 3
Mark M Moasser
Helen Diller Family Comprehensive Cancer Center
Co-authored papers 3
Laura J Van't Veer
University of California San Francisco
Co-authored papers 3
Antonio Sorrentino
Leibniz Institute for Immunotherapy (LIT)
Co-authored papers 3
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 3
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers 2
Aaron N Chang
Baylor College of Medicine
Co-authored papers 2
Mark A LaBarge
Co-authored papers 2
Aaron D Tward
University of California San Francisco
Co-authored papers 2
Rebecca S Levin
Howard Hughes Medical Institute, University of California San Francisco
Co-authored papers 2
Maria M Martins
Stanford University
Co-authored papers 2
Frank McCormick
Frederick National Laboratory for Cancer Research
Co-authored papers 2
Julia A Kaye
J. David Gladstone Institutes
Co-authored papers 2
Valerie M Weaver
University of California san francisco
Co-authored papers 2
William A Weiss
University of California san francisco
Co-authored papers 2
Collin Melton
Stanford University School of Medicine
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Release 1.2